Pharming (PHAR) Payables (2019 - 2025)
Pharming's Payables history spans 7 years, with the latest figure at $105.9 million for Q4 2025.
- Quarterly results put Payables at $105.9 million for Q4 2025, up 58.98% from a year ago — trailing twelve months through Dec 2025 was $105.9 million (up 58.98% YoY), and the annual figure for FY2025 was $105.9 million, up 58.98%.
- Payables for Q4 2025 was $105.9 million at Pharming, up from $66.6 million in the prior quarter.
- In the past five years, Payables ranged from a high of $105.9 million in Q4 2025 to a low of $42.5 million in Q4 2021.
- The 5-year median for Payables is $66.6 million (2024), against an average of $68.4 million.
- The sharpest move saw Payables dropped 8.23% in 2021, then skyrocketed 58.98% in 2025.
- Year by year, Payables stood at $42.5 million in 2021, then rose by 28.23% to $54.5 million in 2022, then surged by 33.16% to $72.5 million in 2023, then dropped by 8.16% to $66.6 million in 2024, then skyrocketed by 58.98% to $105.9 million in 2025.
- According to Business Quant data, Payables over the past three periods came in at $105.9 million, $66.6 million, and $72.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.